In trading on Thursday, shares of Valeant Pharmaceuticals International (NYSE: VRX) touched a new 52-week high of $106.98/share. That's a 103.77% rise, or $54.48 per share from the 52-week low of $52.50 set back on 11/07/2012. That means at today's intraday high, any investor who purchased VRX stock any time over the past 52 weeks has an unrealized gain, including company insiders.
In trading on Thursday, shares of Valeant Pharmaceuticals International (NYSE: VRX) touched a new 52-week high of $106.98/share. That's a 103.77% rise, or $54.48 per share from the 52-week low of $52.50 set back on 11/07/2012. That means at today's intraday high, any investor who purchased VRX stock any time over the past 52 weeks has an unrealized gain, including company insiders.
Share this Article
Recommended